Submit Deal

FRAZIER LIFE SCIENCES

HQ - Palo Alto

Summary

Frazier Life Sciences is a healthcare investment firm focusing on companies developing novel therapeutics from company formation to scale.

Deals Overview

Total Deals18

Valued Deals16

Total Value£ 1.93 B

Avg. Deal Size£ 121 M

Market Context

Senior Management

Albert Cha
Managing Partner
James Li
Venture Partner
Adam Simpson
Venture Partner

Sort

05 Sep 2017|United States|Biotechnology

Target: ENTASIS THERAPEUTICS LIMITED

Bidder: CLARUS VENTURES LLC

3 Service Providers

3 Bidder

1 Dealmakers

3 Bidder

n/a

Value

14 Nov 2022|United States|Pharmaceuticals

Target: MBX BIOSCIENCES

Bidder: WELLINGTON MANAGEMENT

8 Service Providers

3 Target | 5 Bidder

8 Dealmakers

3 Target | 5 Bidder

£ 97 M

Value

25 May 2023|United States|Biotechnology

Target: CARMOT THERAPEUTICS

Bidder: DEEP TRACK CAPITAL

12 Service Providers

2 Target | 10 Bidder

18 Dealmakers

1 Target | 17 Bidder

£ 120 M

Value

20 Dec 2023|United States|Pharmaceuticals

Target: SUDO BIOSCIENCES

Bidder: ENAVATE SCIENCES

7 Service Providers

2 Target | 5 Bidder

7 Dealmakers

2 Target | 5 Bidder

£ 123 M

Value

30 Apr 2024|United States|Biotechnology

Target: ENLAZA THERAPEUTICS

Bidder: AVALON VENTURES INC

4 Service Providers

3 Target | 1 Bidder

3 Dealmakers

2 Target | 1 Bidder

£ 79 M

Value

16 Jul 2024|United States|Biotechnology

Target: SCORPION THERAPEUTICS INC

Bidder: FRAZIER LIFE SCIENCES

5 Service Providers

2 Target | 3 Bidder

5 Dealmakers

3 Target | 2 Bidder

£ 115 M

Value

14 Mar 2024|Germany|Biotechnology

Target: TUBULIS

Bidder: DEEP TRACK CAPITAL

4 Service Providers

2 Target | 2 Bidder

10 Dealmakers

7 Target | 3 Bidder

£ 109 M

Value

12 Aug 2024|United States|Biotechnology

Target: HALDA THERAPEUTICS

Bidder: DEEP TRACK CAPITAL

7 Service Providers

2 Target | 5 Bidder

8 Dealmakers

4 Target | 4 Bidder

£ 99 M

Value

31 Oct 2024|United States|Biotechnology

Target: AEROVATE THERAPEUTICS

Bidder: VENROCK HEALTHCARE CAPITAL PARTNERS

11 Service Providers

4 Target | 7 Bidder

5 Dealmakers

1 Target | 4 Bidder

n/a

Value

03 Dec 2024|United States|Biotechnology

Target: MAZE THERAPEUTICS

Bidder: JANUS HENDERSON INVESTORS

6 Service Providers

3 Target | 3 Bidder

5 Dealmakers

3 Target | 2 Bidder

£ 90 M

Value

23 Oct 2024|Canada|Biotechnology

Target: ALPHA-9 THERANOSTICS

Bidder: GENERAL CATALYST PARTNERS

4 Service Providers

1 Target | 3 Bidder

3 Dealmakers

1 Target | 2 Bidder

£ 139 M

Value

26 Nov 2024|Canada|Biotechnology

Target: 35PHARMA

Bidder: FRAZIER LIFE SCIENCES

3 Service Providers

2 Target | 1 Bidder

5 Dealmakers

4 Target | 1 Bidder

£ 42 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy